Business Briefing | MEDICINE: Drug Maker Withdraws Bid for Obesity Drug Approval
Friday, June 3, 2011 - 20:40
in Health & Medicine
Orexigen Therapeutics, the maker of a weight-loss drug once seen as a potential blockbuster, said it was scrapping its bid for approval in the United States because of “unprecedented” demands by regulators on safety trials.